|
C5ORF51 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.490800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.460600E-01 |
| Normal-vs-Stage2 |
8.200000E-01 |
| Normal-vs-Stage3 |
7.301600E-02 |
| Normal-vs-Stage4 |
7.286200E-02 |
| Stage1-vs-Stage2 |
3.587400E-01 |
| Stage1-vs-Stage3 |
7.205200E-04 |
| Stage1-vs-Stage4 |
1.057940E-03 |
| Stage2-vs-Stage3 |
3.480400E-01 |
| Stage2-vs-Stage4 |
3.510200E-01 |
| Stage3-vs-Stage4 |
9.865800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.511200E-01 |
| Normal-vs-AfricanAmerican |
2.384300E-02 |
| Normal-vs-Asian |
3.154800E-01 |
| Caucasian-vs-AfricanAmerican |
6.021400E-03 |
| Caucasian-vs-Asian |
4.213400E-01 |
| AfricanAmerican-vs-Asian |
3.001700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.516800E-01 |
| Normal-vs-Female |
8.074000E-01 |
| Male-vs-Female |
9.565200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.705800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.391000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.690800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.354360E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.605000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.915400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.913000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.150800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.746550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.294400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.209400E-01 |
| Normal-vs-Grade 2 |
2.394000E-01 |
| Normal-vs-Grade 3 |
3.061400E-01 |
| Normal-vs-Grade 4 |
8.041700E-03 |
| Grade 1-vs-Grade 2 |
6.683800E-01 |
| Grade 1-vs-Grade 3 |
1.671820E-01 |
| Grade 1-vs-Grade 4 |
1.230130E-02 |
| Grade 2-vs-Grade 3 |
7.417600E-03 |
| Grade 2-vs-Grade 4 |
4.44980000000594E-05 |
| Grade 3-vs-Grade 4 |
6.283800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.846500E-02 |
| Normal-vs-ccB subtype |
4.464800E-01 |
| ccA subtype-vs-ccB subtype |
1.024150E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.010000E-01 |
| Normal-vs-N1 |
3.447000E-01 |
| N0-vs-N1 |
4.159400E-01 |
|
|
